Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Cited by (924)

Items 301–400 of 924

1. Near‐Infrared Spectroscopy Reveals Brain Hypoxia and Cerebrovascular Dysregulation in Primary Biliary Cholangitis
   Chris C. Duszynski, Vince Avati, Andrew P. Lapointe, Felix Scholkmann, Jeff F. Dunn, Mark G. Swain · 2019 · Hepatology
2. Clinically significant portal hypertension in patients with primary biliary cholangitis: Clinicopathological features and prognostic value
   Ying Zhang, Huaying Lai, Jing Chen, Ruimin Lai, Xiaoyu Lin, Shan Lin, Bingping Liu, Qiuxiang Lin, Bin Wang, Qi Zheng · 2024 · Annals of Hepatology
3. Safety and efficacy of switching to pemafibrate from bezafibrate in patients with chronic liver disease
   Hideyuki Tamai, Jumpei Okamura · 2022 · Hepatology Research
4. Mechanisms and Treatments of Pruritus in Primary Biliary Cholangitis
   Raj Shah, Kris V. Kowdley · 2019 · Seminars in Liver Disease
5. Molecular Mechanisms of Fibrosis in Cholestatic Liver Diseases and Regenerative Medicine-Based Therapies
   Weilu Wang, Huibin Lian, Yingyu Liang, Yongqin Ye, Paul Kwong Hang Tam, Yan Chen · 2024 · Cells
6. Epidemiology of autoimmune liver disease in Korea: evidence from a nationwide real-world database
   Jihye Lim, Hwa Jung Kim · 2024 · Orphanet Journal of Rare Diseases
7. An enhanced level of LAMP-2A participates in CD4+T cell hyperactivity in patients with primary biliary cholangitis
   Keshuai Sun, Shuoyi Ma, Siyuan Tian, Miao Zhang, Yansheng Liu, Bo Li, Xia Zhou, Xiaohong Zheng, Xinmin Zhou, Lu Wang et al. · 2021 · Annals of Translational Medicine
8. Noninvasive assessment of liver fibrosis in chronic hepatitis B carriers with sound touch elastography: study of surgical pathology specimens
   Lulu Yang, Jiawu Li, Lin Ma · 2020 · Expert Review of Medical Devices
9. Post-Transplant Management and Complications of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis including Disease Recurrence
   Jacqueline B. Henson, Lindsay Y. King · 2023 · Clinics in Liver Disease
10. The treatment of primary biliary cholangitis: from shadow to light
    Sylvia Dražilová, Tomáš Koky, Marian Macej, Martin Janíčko, Dagmar Simkova, Peter Jarčuška · 2024 · Therapeutic Advances in Gastroenterology
11. Risk Stratification in Primary Biliary Cholangitis
    Francesco Martini, Daniele Balducci, Martina Mancinelli, Valerio Buzzanca, Elena Fracchia, Giuseppe Tarantino, A. Benedetti, Marco Marzioni, Luca Maroni · 2023 · Journal of Clinical Medicine
12. HSCs-derived exosomes regulate the levels of inflammatory cytokines in HIBECs through miR-122-5p mediated p38 MAPK signaling pathway
    Yaqin Zhang, Xiangzhi Zhang, Ruofei Chen, Ziying Jiao, Bing Q. Shen, Zongwen Shuai · 2024 · Genomics
13. Care of the Patient With Abnormal Liver Test Results
    Ashley N. Tran, Joseph K. Lim · 2021 · Annals of Internal Medicine
14. Management of Autoimmune Liver Diseases after Liver Transplantation
    Romelia Barba, Esli Medina‐Morales, Daniela Goyes, Vilas R. Patwardhan, Alan Bonder · 2021 · Transplantology
15. Primary biliary cholangitis: review for radiologists
    Matthew A. Morgan, Karthik M. Sundaram · 2021 · Abdominal Radiology
16. Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments
    Filippo Gabrielli, Eleonora Crepaldi, Alessia Cavicchioli, Marco Rivi, Arianna A.C. Costanzo, Carmela Cursaro, Pietro Andreoné · 2024 · Biomolecules
17. Florid biliary duct lesions in an AMA -positive patient in absence of cholestatic liver biochemistry
    Khaleel Sultan, Mahir Abdulla Petkar, Moutaz F. M. Derbala · 2019 · Journal of Autoimmunity
18. Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders
    Federica Di Vincenzo, Alberto Nicoletti, Marcantonio Negri, Federica Vitale, Lorenzo Zileri Dal Verme, Antonio Gasbarrini, Francesca Romana Ponziani, Lucia Cerrito · 2023 · Antibiotics
19. Joint Analysis of Genetic Correlation, Mendelian Randomization and Colocalization Highlights the Bi-Directional Causal Association Between Hypothyroidism and Primary Biliary Cirrhosis
    Yanjun Wang, Ping Guo, Yanan Zhang, Lu Liu, Ran Yan, Zhongshang Yuan, Yongfeng Song · 2021 · Frontiers in Genetics
20. Tauroursodeoxycholic acid targets HSP90 to promote protein homeostasis and extends healthy lifespan
    Jiayu Liu, Yao Wang, Yue Guo, Run-Qi Zheng, Yunying Wang, Yanyan Shen, Yanhong Liu, Ai-Ping Cao, Ruibo Wang, Bo-Yang Xie et al. · 2024 · Science China Life Sciences
21. Similar clinical outcome of AMA immunoblot-M2-negative compared to immunoblot-positive subjects over six years of follow-up
    Stephan Zandanell, Michael Straßer, Alexandra Feldman, Georg Strebinger, Gerhild Aigner, David Niederseer, Martin Laimer, Birgit Mussnig, Bernhard Paulweber, Christian Datz et al. · 2021 · Postgraduate Medicine
22. Primary Biliary Cholangitis Guidance Update: Implications for Liver Transplantation
    C. Levy · 2018 · Liver transplantation
23. Assessment of PBC Pruritus From the ITCH ‐E Study: Quality of Life, Productivity, and Treatment Experiences
    Cynthia Levy, Zobair M. Younossi, Marlyn J. Mayo, Andreas Emanuel Kremer, Jennifer Pate, Jonathan Ieyoub, Rebekah M. Zincavage, Brad Padilla, Diane Ito, Carla Perez · 2025 · Liver International
24. Diagnostic and prognostic value of quantitative detection of antimitochondrial antibodies subtype M2 using chemiluminescence immunoassay in primary biliary cholangitis
    Miaochan Wang, Yujiao Jin, Aifang Xu · 2023 · Clinical Chemistry and Laboratory Medicine (CCLM)
25. Cholestatic liver diseases: modern therapeutics
    Bridgette B. McNally, Elizabeth J. Carey · 2025 · Expert Review of Gastroenterology & Hepatology
26. Overview of autoimmune liver disease: Prevalence, risk factors, and role of autoantibodies
    Dong Xi, Henry C. Lin, Amit A. Shah · 2022 · Clinical Liver Disease
27. Factors associated with severity and persistence of fatigue in patients with primary biliary cholangitis: study protocol of a prospective cohort study with a mixed-methods approach (SOMA.LIV)
    Anne Christin Toussaint, Laura Buck, Johannes Hartl, Bernd Löwe, Christoph Schramm · 2022 · BMJ Open
28. Serum Gas6 and Axl as non‐invasive biomarkers of advanced histological stage in primary biliary cholangitis
    Manabu Hayashi, Kazumichi Abe, Masashi Fujita, Atsushi Takahashi, Yuko Hashimoto, Hiromasa Ohira · 2020 · Hepatology Research
29. Combination antiretroviral therapy improves recurrent primary biliary cholangitis following liver transplantation
    Ellina Lytvyak, Mina Niazi, Rohit Pai, Daniel He, Guangzhi Zhang, Stefan G. Hübscher, Andrew L. Mason · 2021 · Liver International
30. Aberrant cytokeratin 7 expression by hepatocytes can predict the ductopenia grade in primary biliary cholangitis
    Hongli Liu, An-Yin Yang, Qing‐Fang Xiong, Yan-Dan Zhong, Du-Xian Liu, Ping Cheong Huang, Xiaoning Feng, Yu Zhang, Yongfeng Yang · 2022 · BMC Gastroenterology
31. Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases
    Marilena Durazzo, Arianna Ferro, Victor Navarro‐Tableros, Andrea Gaido, Paolo Fornengo, Fiorella Altruda, Renato Romagnoli, Søren K. Moestrup, Pier Luigi Calvo, Sharmila Fagoonee · 2025 · Biomolecules
32. High neutrophil-lymphocyte ratio indicates a worse response to ursodeoxycholic acid in primary biliary cholangitis: a retrospective cohort study
    Huiling Zhu, Mengyao Zheng, Haiyu He, Hongtao Lei, Wenlin Tai, Jinhui Yang · 2023 · BMC Gastroenterology
33. Linking Human Betaretrovirus with Autoimmunity and Liver Disease in Patients with Primary Biliary Cholangitis
    Hussain Syed, Tara Penner, Andrew L. Mason · 2022 · Viruses
34. Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients
    Maja Mijić, Ivona Saric, Božena Delija, Miloš Lalovac, Nikola Sobočan, Eva Radetić, Dora Martinčević, Tajana Filipec Kanižaj · 2022 · Canadian Journal of Gastroenterology and Hepatology
35. Paediatric-onset autoimmune liver disease: Insights from a monocentric experience
    Franco Curci, Chiara Rubino, Mariangela Stinco, Simona Carrera, Sandra Trapani, Elisa Bartolini, Giuseppe Indolfi · 2024 · Digestive and Liver Disease
36. Cholestatic Liver Disease and Pregnancy: A Systematic Review and Meta-Analysis
    Bryan W. Ferrigno, Romelia Barba, Esli Medina‐Morales · 2022 · Journal of Clinical Medicine
37. Managing the Symptoms and Complications of Cholestasis
    Mark R. Pedersen, Marlyn J. Mayo · 2020 · Clinical Liver Disease
38. Primary Biliary Cholangitis: Promising Emerging Innovative Therapies and Their Impact on GLOBE Scores
    Aalam Sohal, K. Kowdley · 2023 · Hepatic Medicine : Evidence and Research
39. Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2025
    Fabiana Hanna Rached, Marcio Hiroshi Miname, Viviane Zorzanelli Rocha, André Zimerman, Fernando Yue Cesena, Andrei Carvalho Sposito, Raul Dias Santos, Paulo Eduardo Ballvé Behr, Henrique Tria Bianco, Renato Jorge Alves et al. · 2025 · Arquivos Brasileiros de Cardiologia
40. Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acid
    Da-Wei Ding, P. Ren, Guan-Ya Guo, Yan-Sheng Liu, Chun-Mei Yang, Lin-Hua Zheng, G. Jia, Juan Deng, Rui-Xing Sun, Xiu-Fang Wang et al. · 2023 · Gastroenterology & hepatology
41. Treatment of Alcohol Use Disorder
    Kinza Tareen, Erin G. Clifton, Ponni Perumalswami, Jessica Leigh Mellinger, Gerald Scott Winder · 2024 · Clinics in Liver Disease
42. Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis—methylomics of cholestatic liver disease
    Brian D. Juran, Bryan M. McCauley, Elizabeth J. Atkinson, Erik M. Schlicht, Jackie K. Bianchi, Jason M. Vollenweider, Hong Ye, Nicholas F. LaRusso, Gregory James Gores, Zhifu Sun et al. · 2024 · Hepatology Communications
43. Pemafibrate improves liver biochemistry and GLOBE scores in patients with primary biliary cholangitis: Nationwide, multicenter study by the Japanese Red Cross Liver Study Group
    Keiji Tsuji, Nobuharu Tamaki, Masayuki Kurosaki, Nami Mori, Shintaro Takaki, Kazuki Ohya, Toshie Mashiba, Hironori Ochi, Haruhiko Kobashi, Chikara Ogawa et al. · 2025 · Hepatology Research
44. Investigational drugs in early phase development for primary biliary cholangitis
    Eric M. Gochanour, Kris V. Kowdley · 2020 · Expert Opinion on Investigational Drugs
45. Psychometric validation of the Worst Itch Numerical Rating Scale (WI-NRS) and other patient-reported outcome measures for assessing severity and impact of pruritus in patients with primary biliary cholangitis
    Heather L. Gelhorn, Brooke M. Currie, Donald M. Bushnell, Mona L. Martin, Fatoumata Fofana, Hayley Karn, Marlyn J. Mayo, David E. Jones, Megan McLaughlin, Robyn von Maltzahn · 2025 · Orphanet Journal of Rare Diseases
46. Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019
    Kyung‐Ah Kim, Hwa Young Choi, Moran Ki, Eun Sun Jang, Sook‐Hyang Jeong · 2023 · Journal of Gastroenterology
47. Quantitative Detection of 15 Serum Bile Acid Metabolic Products by LC/MS/MS in the Diagnosis of Primary Biliary Cholangitis
    Dan Liu, Li Guo, Dongdong Liu · 2023 · Chemistry & Biodiversity
48. Advancing Second-Line Treatment for Primary Biliary Cholangitis
    David N. Assis · 2024 · New England Journal of Medicine
49. Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers
    Sohan Punia, Brian D. Juran, Ahmad Hassan Ali, Erik M. Schlicht, Raymond M. Moore, Zhifu Sun, Konstantinos N. Lazaridis · 2021 · BMC Gastroenterology
50. Alkaline phosphatase and liver fibrosis at diagnosis are associated with deep response to ursodeoxycholic acid in primary biliary cholangitis
    Guilherme Grossi Lopes Cançado, Patrícia da Silva Fucuta, Nathália Mota de Faria Gomes, Cláudia Alves Couto, Eduardo Luiz Rachid Cançado, Débora Raquel Benedita Terrabuio, Cristiane Alves Villela‐Nogueira, Michelle Harriz Braga, Mateus Jorge Nardelli, Luciana Costa Faria et al. · 2024 · Clinics and Research in Hepatology and Gastroenterology
51. Bioinformatic analysis identified novel candidate genes with the potentials for diagnostic blood testing of primary biliary cholangitis
    Hoang Nam Pham, Linh Pham, Keisaku Sato · 2023 · PLoS ONE
52. Development and validation of machine learning model for predicting treatment responders in patients with primary biliary cholangitis
    Naruhiro Kimura, Kazuya Takahashi, Toru Setsu, Yusuke Horibata, Yusuke Kaneko, Haruka Miyazaki, Kohei Ogawa, Yuzo Kawata, Norihiro Sakai, Yusuke Watanabe et al. · 2023 · Hepatology Research
53. Treatment Persistence, Normal Alkaline Phosphatase and Clinical Outcomes in Primary Biliary Cholangitis
    Kris V. Kowdley, Jonathan Ieyoub, Yi Pan, Mihail Samnaliev, Diane Ito, Carla Perez · 2025 · Alimentary Pharmacology & Therapeutics
54. Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
    Jinyu Zhao, Ping Yue, Ningning Mi, Matu Li, Wenkang Fu, Xianzhuo Zhang, Long Gao, Mingzhen Bai, Liang Tian, Ningzu Jiang et al. · 2024 · Medical Review
55. Intrahepatic activated leukocyte cell adhesion molecule induces CD6highCD4+ T cell infiltration in autoimmune hepatitis
    Qiwei Qian, Nana Cui, Bingyuan Huang et al. · 2022 · Frontiers in Immunology
56. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases
    Henrique Carvalho Rocha, Eduardo García Vilela · 2021 · Gastroenterología y Hepatología
57. Research progress on the application of single-cell sequencing in autoimmune diseases
    Xueli Yang, Xianliang Hou, Junning Zhang, Zhenyu Liu, Guangyu Wang · 2023 · Genes and Immunity
58. Incomplete response to ursodeoxycholic acid in primary biliary cholangitis: criteria, epidemiology, and possible mechanisms
    Lin Huang, Zi-Long Wang, R. Jin, Hong-Song Chen, Bo Feng · 2022 · Expert Review of Gastroenterology & Hepatology
59. 3β-Isoobeticholic acid efficiently activates the farnesoid X receptor (FXR) due to its epimerization to 3α-epimer by hepatic metabolism
    Alžběta Štefela, Miroslav Kašpar, Martin Drastík, Ondřej Holas, Milos Hroch, Tomáš Smutný, Josef Škoda, Miriama Hutníková, Amit V. Pandey, Stanislav Mičuda et al. · 2020 · The Journal of Steroid Biochemistry and Molecular Biology
60. The Albumin-Bilirubin Score as a Predictor of Liver-Related Mortality in Primary Biliary Cholangitis with Compensated Cirrhosis
    Qingling Chen, Rui Zhong, Yaoping Wang, Y. Kui, X. Wen, Jianjie Huang, Q. Jin · 2023 · Digestive Diseases
61. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting
    Dustin E. Bosch, Yoh Zen, Sarag Boukhar, Yong-Jun Liu, Lin Cheng, Matthew M. Yeh · 2021 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
62. Posttransplant immune-mediated cholangiopathies
    Jérôme Dumortier, Filoména Conti, Jean‐Yves Scoazec · 2021 · Current Opinion in Gastroenterology
63. Primary Biliary Cholangitis: A Review
    Helen Z. Xu, Beshoy Yanny · 2022 · Gene Expression
64. An involvement of Hippo-yes-associated protein pathway in biliary epithelial senescence in primary biliary cholangitis
    Motoko Sasaki, Yasunori Sato, Yasuni Nakanuma · 2023 · Clinics and Research in Hepatology and Gastroenterology
65. Estrogen receptor alpha‐mediated mitochondrial damage in intrahepatic bile duct epithelial cells leading to the pathogenesis of primary biliary cholangitis
    Mengting Liang, Siwen Ye, Rubin Jing, Bukun Zhu, Wenjie Yuan, Xi Chu, Ying Li, Wei Zhang · 2023 · Environmental Toxicology
66. Liver Biopsy: To Do or Not to Do – A Single-Center Study
    Θεόδωρος Ανδρουτσάκος, Konstantinos Dimitriadis, Konstantinos Revenas · 2023 · Digestive Diseases
67. Evolving therapeutic landscape of primary biliary cholangitis: A review
    Natalie E. Mitchell, Shu‐Yen Chan, David Jerez Diaz, Nida Ansari, J.S. Lee, Patrick A. Twohig · 2025 · World Journal of Hepatology
68. Prognostic scores in primary biliary cholangitis patients with advanced disease
    Juan Feng, Jia-min Xu, Hai-Yan Fu, Nan Xie, Weimin Bao, Ying-Mei Tang · 2023 · World Journal of Gastrointestinal Surgery
69. A heterogeneous subtype of biliary epithelial senescence may be involved in the pathogenesis of primary biliary cholangitis
    Motoko Sasaki, Yasunori Sato, Yasuni Nakanuma · 2024 · Clinics and Research in Hepatology and Gastroenterology
70. Development and external validation of an early prediction model to identify irresponsive patients and prognosis of UDCA treatment in primary biliary cholangitis
    Huiling Zhu, Mengyao Zheng, Haiyu He, Hongtao Lei, Wenlin Tai, Jinhui Yang, Zhengji Song · 2024 · Scientific Reports
71. Clinical and Biochemical Characteristics of a Danish and Turkish Cohort of Incident and Prevalent Patients with Primary Biliary Cholangitis
    Hasan Eruzun, Lars Bossen, Dilara Turan Gökçe, İlkay Ergenç, Zekiye Nur Harput, Neslihan Güneş Aydemir, Meral Akdoğan, Hasan Basri Yapıcı, Tugay Doğan, Peter Holland‐Fischer et al. · 2025 · The Turkish Journal of Gastroenterology
72. Circulating Monocyte Chemoattractant Protein-1 (MCP-1) in Patients with Primary Biliary Cholangitis
    Alicja Bauer, Tomasz Rawa · 2024 · International Journal of Molecular Sciences
73. Pathogenesis and management of fatigue in primary biliary cholangitis
    Dana Shamshtein, Timur Liwinski · 2022 · Fatigue Biomedicine Health & Behavior
74. The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis
    Lars Bossen, Tobias Stemann Lau, Mette Bak Nielsen, Marlene Christina Nielsen, Astrid Højmark Andersen, Peter Ott, Sabine Becker, Henning Glerup, Lise Svenningsen, Martin Eivindson et al. · 2023 · Hepatology Communications
75. An Integrated Pathogenetic Model of Primary Biliary Cholangitis
    Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki · 2025 · Livers
76. Oxidative stress-related markers as prognostic factors for patients with primary sclerosing cholangitis in Japan
    Atsushi Oyama, Akinobu Takaki, Takuya Adachi, Nozomu Wada, Yasuto Takeuchi, Hideki Onishi, Hidenori Shiraha, Hiroyuki Okada, Motoyuki Otsuka · 2023 · Hepatology International
77. Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis
    Troy D. Jaskowski, Vijayalakshmi Nandakumar, Camille L. Novis, Michael Palmer, Anne E. Tebo · 2023 · Clinica Chimica Acta
78. Advancing the management of primary biliary cholangitis: From pathogenesis to emerging therapies
    A. Curto, Rocco Gabriele Iamello, Erica Nicola Lynch, Andrea Galli · 2025 · World Journal of Clinical Cases
79. Considerations in the Diagnoses and Management of Hepatic Disease in Older Adults
    Cristal L. Brown, Jasmohan Singh Bajaj · 2025 · The American Journal of Gastroenterology
80. Safety considerations for the management of cholestatic itch
    Juan Pablo Trivella, Cynthia Levy · 2021 · Expert Opinion on Drug Safety
81. Analytical and clinical performance of different platforms simultaneously detecting 15 antinuclear antibodies
    Yan Qin, Chunxue Fan, Yanlin Wang, Min Feng, Zhaojun Liang, Xiangcong Zhao, Chong Gao, Jing Luo · 2022 · Journal of Clinical Laboratory Analysis
82. Efficacy and Safety of Obeticholic Acid as Second‐Line Therapy in Primary Biliary Cholangitis: Systematic Review and Meta‐Analysis
    Eliabe Silva de Abreu, Gabriel Prusch Fernandes, Henrique Lacerda, Pedro Henrique Reginato, Henrique Alexsander Ferreira Neves, Carlos Danilo Sanchez Gonzalez, John E. Eaton, Guilherme Grossi Lopes Cançado · 2025 · Journal of Gastroenterology and Hepatology
83. Bibliometric analysis of research on intestinal flora and primary biliary cholangitis published between 2004 and 2024 using VOSviewer and CiteSpace visualization
    Tao Li, Wang Jing · 2025 · Frontiers in Medicine
84. Longitudinal Assessment of Bile Duct Loss in Primary Biliary Cholangitis
    Julian Hercun, Mazen Noureddin, Nabil Noureddin, Jason L. Eccleston, Daniel Woolridge, T. Jake Liang, Michele May-Sien Tana, David Erwin Kleiner, Gracia Viana Rodriguez, Christopher Koh et al. · 2022 · The American Journal of Gastroenterology
85. A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis
    Larissa Akeme Nakano, Eduardo Luiz Rachid Cançado, Cleuber Esteves Chaves et al. · 2020 · BMC Gastroenterology
86. Depressive symptom as a risk factor for cirrhosis in patients with primary biliary cholangitis: Analysis based on Lasso‐logistic regression and decision tree models
    Simin Zhou, Jiwen Li, Jiangpeng Liu, Shijing Dong, Nian Chen, Ying Ran, Haifeng Liu, Xiaoyi Wang, Hui Yang, Man Liu et al. · 2024 · Brain and Behavior
87. Natural History and Predictors of Clinical Outcomes in Autoimmune Liver Diseases: A Multicenter Study
    Dujinthan Jayabalan, Yi‐Hsiang Huang, Luis Calzadilla Bertot et al. · 2024 · Journal of Gastroenterology and Hepatology
88. Total bile acid to platelet ratio
    Minjie Jiang, Xin Yan, Xinyue Song, Qi Yan, Youyou Zhao, Luyuan Wang, Pujun Gao · 2020 · Medicine
89. Prediction and Evaluation of High-risk Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid Therapy: An Early Criterion
    Chunmei Yang, Guanya Guo, Bo Li et al. · 2022 · Research Square
90. Drug Design Strategies, Modes of Action, Synthesis and Industrial Challenges Behind Trifluoromethylated New Chemical Entities
    Leitao EPT, Sobral LMS · 2024 · Journal of Biomedical Research & Environmental Sciences
91. Autoantibodes to GP210 are a metric for UDCA responses in primary biliary cholangitis
    Chan Wang, Zhuye Qin, Mingming Zhang, Yaping Dai, Luyao Zhang, Wenyan Tian, Yuhua Gong, Sufang Chen, Can Yang, Ping Xu et al. · 2024 · Journal of Translational Autoimmunity
92. Liver Disease and Hemostasis (Review) Part 2. Cholestatic Liver Disease and Hemostasis
    Vasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev, Tatiana Magomedalievna Reshetnyak, Sergey Vladimirovich Zhuravel, Владимир Митрофанович Писарев · 2019 · General Reanimatology
93. A Closer Look into Autoimmune Liver Diseases
    Branka F. Filipović, Marija Marjanovic-Haljilji, Dragana Blagojevic, Milica Dragovic, Emilija Krsmanovic, Ana Matovic, Natasa Panic, Stanimir Kiurski, Zagor Zagorac, Miljan Milanović et al. · 2025 · International Journal of Molecular Sciences
94. Efficacy of ursodeoxycholic acid for bile reflux after distal gastrectomy in patients with gastric cancer: a secondary analysis of the PEGASUS-D randomized clinical trial
    Dong Kee Jang, Young Suk Park, Moon‐Won Yoo et al. · 2024 · International Journal of Surgery
95. Causal effect of adiposity on the risk of 19 gastrointestinal diseases: a Mendelian randomization study
    2021
96. Cumulative risk of developing a new symptom in patients with primary biliary cholangitis and its impact on prognosis
    Naruhiro Kimura, Toru Setsu, Yoshihisa Arao, Norihiro Sakai, Yusuke Watanabe, Hiroyuki Abé, Hiroteru Kamimura, Akira Sakamaki, Takeshi Yokoo, Kenya Kamimura et al. · 2022 · JGH Open
97. PBC: No Longer a Western Disease?
    Atsushi Tanaka · 2020 · Clinical Liver Disease
98. S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)
    Autorinnen/Autoren, Collaborators · 2025 · Zeitschrift für Gastroenterologie
99. A Clinical Review of Primary Biliary Cholangitis
    Richard L. Pullen · 2020 · Gastroenterology Nursing
100. The etiology and differential diagnosis of “autoimmune hepatitis-like liver disease” in children: a single-center retrospective study
     Di Ma, Xinglou Liu, Guo Ai, Wen Qi Pan, Lingling Liu, Yuan Huang, Yi Liao, Yuanyuan Lu, Zhan Zhang, Hua Zhou et al. · 2024 · Frontiers in Pediatrics